NovaBay Pharmaceuticals (NBY)

0.95 -0.01  -1.05%  May 30, 8:00PM Go Pro
Watch this stock
View Full Chart NBY Price Chart

Key Stats

Market Cap 27.47M
Revenue Growth -46.99%
Profit Margin -191.7%
Earnings Yield -22.11%
Dividend Yield 0.00%
Earnings Per Share TTM -0.21
PE Ratio
Price / Sales Ratio 2.790
52 Week High 1.72
52 Week Low 0.67
Beta 0.6849
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

Profile

Exchange: AMEX       Sector: Healthcare       Industry: Drug Manufacturers - Other

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NovaBay Pharmaceuticals is down 43.11% over the last year vs S&P 500 Total Return up 0.88%, Allergan up 10.03%, and Tianyin Pharmaceutical down 72.09%.

  • NBY Total Returns
  • ^SPXTR Total Returns
  • AGN Total Returns
  • TPI Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring NBY

Did NovaBay Pharmaceuticals make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

NBY Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
NBY 0.95 -0.01 -1.05% 27.47M
NBTB 19.71 -0.65 -3.19% 655.16M
NBR 13.76 -0.56 -3.91% 3.972B
NBL 84.04 -2.17 -2.52% 15.02B
NBIX 6.45 -0.08 -1.23% 427.25M
NBG 1.44 -0.08 -5.26% 1.377B
MOC 1.10 +0.01 +0.92% 11.81M
MOBI 2.11 -0.08 -3.65% 67.88M
MO 32.02 -0.11 -0.34% 65.50B
MNTG 4.90 +0.11 +2.30% 135.58M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close